Dermatologic drug development involves the creation and testing of new medications specifically designed to treat a wide range of skin conditions, from common issues like acne and eczema to more complex diseases such as psoriasis and skin cancer. The process of developing dermatologic drugs requires a thorough understanding of skin biology, as well as how drugs interact with the skin's layers and systems. Advances in dermatologic drug development have led to targeted therapies, such as biologics and topical immunomodulators, which offer more precise and effective treatments with fewer side effects compared to traditional options. In addition to systemic treatments, innovations in drug delivery systems, such as nanoparticles and liposomes, are improving the effectiveness and penetration of topical treatments. Dermatologic drug development also focuses on personalized medicine, tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. As research progresses, new therapies continue to emerge, offering better management and potential cures for a range of dermatological diseases.
Sergei A Grando
University of California Irvine, United States
Nalini Kaul
Princeton Consumer Research, Canada
Dechelette Corinne
La Peau Autrement, France
Salma Bennis
Nova Southeastern University, United States
Diane Madfes
Madfes Aesthetic Medical Center, United States
Abdullah Abdullah
Newham University Hospital, United Kingdom
Chajra Hanane
Activen, Switzerland
Dunia Battolla
Hapiderm Clinic, Switzerland
Camille Ysabel V Bautista
Jose R. Reyes Memorial Medical Center, PhilippinesSubmit your abstract Today
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Paraneoplastic Autoimmune Multiorgan Syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Art, skin, and dermatology: Interdisciplinary perspectives
Dechelette Corinne, La Peau Autrement, France
Title : Personalized and Precision Medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Lymphoproliferative diseases in the practice of a dermatologist
Sergeeva Irina, Novosibirsk State University, Russian Federation
Title : Assessing efficacy and safety of hair growth products in a clinical design using qualitative and quantitative techniques
Nalini Kaul, Princeton Consumer Research, Canada
Title : Integrating personalized and precision medicine into dermatology clinical practice securing its potential to get skin diseases cured and to revolutionize dermatooncology
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, The Clinic of Plastic Surgery and Aesthetic Dermatology, Totalcharm, Georgia
Title : How a combined use of stem cells and laser technologies for face and neck rejuvenation can reduce patients’request for surgical correction
Elena Giardini, Private Practice, Italy
Title : Demographic and clinical profile of allergic contact dermatitis patients who tested positive with metal allergy from a tertiary hospital: A 12 year retrospective study
Camille Ysabel V Bautista, Jose R. Reyes Memorial Medical Center, Philippines